Intuitive Surgical (NASDAQ:ISRG – Get Rating) had its price target dropped by Wells Fargo & Company from $350.00 to $339.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s target price suggests a potential upside of 15.08% from the company’s previous close.
Other equities research analysts have also issued reports about the stock. Wolfe Research initiated coverage on shares of Intuitive Surgical in a research report on Tuesday, April 5th. They set a “peer perform” rating and a $315.00 target price on the stock. Bank of America started coverage on Intuitive Surgical in a research note on Tuesday, March 1st. They set a “buy” rating for the company. Evercore ISI cut their price target on Intuitive Surgical from $294.00 to $280.00 in a research note on Friday. Deutsche Bank Aktiengesellschaft cut their price target on Intuitive Surgical from $323.00 to $300.00 and set a “hold” rating for the company in a research note on Friday, January 21st. Finally, BTIG Research cut their price target on Intuitive Surgical from $372.00 to $360.00 and set a “buy” rating for the company in a research note on Friday, January 21st. Seven equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $332.91.
NASDAQ ISRG opened at $294.57 on Friday. The stock has a market capitalization of $105.81 billion, a P/E ratio of 63.12, a P/E/G ratio of 7.12 and a beta of 1.17. Intuitive Surgical has a 52-week low of $254.20 and a 52-week high of $369.69. The firm has a 50-day moving average price of $287.16 and a 200 day moving average price of $315.27.
In other Intuitive Surgical news, EVP Robert Desantis sold 1,410 shares of the company’s stock in a transaction that occurred on Tuesday, January 25th. The stock was sold at an average price of $261.64, for a total value of $368,912.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 2,478 shares of the company’s stock in a transaction that occurred on Wednesday, February 16th. The shares were sold at an average price of $289.00, for a total value of $716,142.00. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the business. Hexagon Capital Partners LLC raised its position in shares of Intuitive Surgical by 200.0% in the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 46 shares in the last quarter. Paragon Capital Management Ltd acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. Hanseatic Management Services Inc. raised its position in shares of Intuitive Surgical by 200.0% in the 4th quarter. Hanseatic Management Services Inc. now owns 72 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 48 shares in the last quarter. Standard Family Office LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $27,000. Finally, Wolff Wiese Magana LLC raised its position in shares of Intuitive Surgical by 1,000.0% in the 4th quarter. Wolff Wiese Magana LLC now owns 77 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 70 shares in the last quarter. 44.03% of the stock is currently owned by institutional investors.
Intuitive Surgical Company Profile (Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- Snap (NYSE: SNAP) Gives Investors A Mixed Bag
- MarketBeat Podcast: 3 Stocks Flashing Buy Signals
- Should You Buy Carvana or AutoNation or Pass on Both?
- What Should Investors Take Away From Boston Beer’s Earnings?
- High-Yield Kinder Morgan Is Still A Buy
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.